Science abstracts on CBD and Alzheimer's & Dementia

• Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease
• The therapeutic potential of the endocannabinoid system for Alzheimer’s disease
• Endocannabinoid signalling in Alzheimer’s disease
• A molecular link between the active component of marijuana and Alzheimer’s disease pathology
• Neuroprotective effect of CBD… on beta-amyloid-induced toxicity in PC12 cells
• The Potential Therapeutic Effects of THC on Alzheimer’s Disease
• The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease
• Cannabinoids for the treatment of dementia
• CBD in vivo blunts beta-amyloid induced neuroinflammation by suppressing IL-1beta and iNOS expression
• CBD: A promising drug for neurodegenerative disorders?
• Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition
• The role of the endocannabinoid system in Alzheimer’s disease
• The role of phytochemicals in the treatment and prevention of dementia
• Cannabinoids for the treatment of dementia
• Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement
• Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
• Can Marijuana Prevent Alzheimer’s?
• Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia
• Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview
• Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model
• CBD Modulates the Expression of Alzheimer’s Disease-Related Genes in Mesenchymal Stem Cells
• In vivo Evidence for Therapeutic Properties of CBD for Alzheimer's Disease
• Neurological aspects of medical use of CBD

These links are from third-party sites and are provided as a courtesy to the reader.